ascopubs.org26d
Caring for the Family Caregiver in Oncology
Insights and Limitations of the Study on Temporary Interruption of Endocrine Therapy and Assisted Reproductive Technology Use in Breast Cancer Survivors In the article that accompanies this editorial, ...
ascopubs.org15d
Patient Enrollment to Industry-Sponsored Versus Federally Sponsored Cancer Clinical Trials
The conduct of cancer clinical research in the United States is supported by both private and public sponsors. Industry aims to obtain new drug approvals. Federally sponsored trials examine a broad ...
ascopubs.org10d
Long-Term Risk of Subsequent Neoplasms in 5-Year Survivors of Childhood Neuroblastoma: A Dutch Childhood Cancer Survivor Study-LATER 3 Study
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma Authors ...
ascopubs.org8d
Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...
ascopubs.org8d
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...
ascopubs.org9d
Intersectionality Between Country, Gender and Funding in Authorship for Phase III Trials Presented at the ASCO Annual Meeting 2022
Multiple disparities have been recognized in the area of location, gender, and funding for leadership in oncology clinical trials. Understanding their intersectionality is crucial to be able to ...
ascopubs.org10d
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma Using pooled ...
ascopubs.org11d
Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled Trial
Can We Find a Place for Trophoblast Cell Surface Antigen 2–Targeted Antibody-Drug Conjugates in Lung Cancer? Sixteen towns in Sihui and Zhongshan cities, China, were selected; eight were randomly ...
ascopubs.org11d
On the Nose: Reducing Nasopharyngeal Cancer–Related Mortality Using Risk-Based Epstein-Barr Virus Serology Screening
The study demonstrated that a risk-based screening algorithm for nasopharyngeal cancer (NPC) control in a high-risk population is effective, and several refinements to this algorithm to improve ...
ascopubs.org10d
Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis: One Decade Later
In 2012, the National Academies of Sciences, Engineering, and Medicine convened a committee charged with addressing the quality of cancer care in the United States and providing recommendations to ...
ascopubs.org12d
Implementation and improvement of a routine suicidal ideation screening process for an ambulatory, academic NCCN-designated center.
Kaizen-led utilization improvement at medical oncology daycare unit.
ascopubs.org12d
Surviving is just the beginning: Exposing unmet needs of cancer survivors through a patient-informed lens.
“Tell me I’m okay”: A cross-sectional quality-of-life assessment of patients in a breast cancer survivorship program. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This ...